OTC market in Central and Eastern Europe 2008 Comparative analysis and development forecasts for

Similar documents
Non-pharmacy OTC market in Poland 2008

Construction sector in Kazakhstan 2008 Development forecasts for Publication date: June 2008 Language: English

OTC market in Russia Development forecasts for

OTC market in CIS countries Russia, Ukraine and Kazakhstan. Comparative analysis and development forecasts for

Railway. construction sector in Poland 2012 Development forecasts for Publication date: Q Language: Polish, English

FREE ARTICLE. Russian pharmaceutical market overview. Source: Pharma Poland News

OTC market in the Czech Republic Development forecasts for

OTC market in CIS countries Comparative analysis and development forecasts for

INVESTMENT FUNDS AND ASSET MANAGEMENT MARKET IN POLAND,

INVESTMENT FUNDS AND ASSET MANAGEMENT MARKET IN POLAND,

Investment Funds and Asset Management in Poland,

ESTONIA, LATVIA, LITHUANIA - BANKING MARKET IN THE BALTICS CEE BANKING BRIEF

INVESTMENT FUNDS AND ASSET MANAGEMENT MARKET IN POLAND,

BGŻ Group. Presentation of H results. Warsaw, 13 August 2013

Ukraine FDI report 2011

The contents of this document must be taken into account by all individuals or entities that may have to make decisions or draw up or

MORTGAGE LENDING IN POLAND

BGŻ Group. Presentation of Q results. Warsaw, November 7th, 2014

SELECTED FINANCIAL DATA

Re.: Systemic harmonisation with CSDR requirements Phase 1 (2017 spring implementation window)

by Intelace Research November 2010 Version: 10.01

Corporate Presentation

BGŻ Group. Presentation of H results. Warsaw, August 13, 2014

CONSOLIDATED INTERIM FINANCIAL STATEMENTS OF THE GROUP CCC S.A. FOR Q1 2017

Travel Insurance and Assistance in Northern, Central and Eastern Europe

AB S.A. Capital Group SUPPLEMENTARY REPORT TO THE OPINION ON THE AUDIT OF THE CONSOLIDATED FINANCIAL STATEMENTS AS AT

EXHIBITION ORDER FORM AND CONTRACT

PwC. Central & Eastern European Mergers & Acquisition Survey 2005* Romania Report. *connectedthinking. Introduction

Online Insurance Europe: BEST PRACTICES & TRENDS

THE FUTURE OF CASH AND PAYMENTS

NOTICE OF THE ANNUAL GENERAL MEETING

SELECTED FINANCIAL DATA

Current report 40/2016 Orange Polska S.A. 21 June 2016

Banking Market Overview

BANK POLSKA KASA OPIEKI S.A. WARSAW, GRZYBOWSKA 53/57 FINANCIAL STATEMENTS FOR THE 2017 FINANCIAL YEAR WITH AUDITOR S REPORT

Romania the next best thing. Generali Romania November 12, 2009 Bucharest

EPC and the Central and Eastern European. Dr Krzysztof Oplustil Jagiellonian University, Kraków

Drug Reimbursement - Croatia. Roganovic Jelena

CONSOLIDATED HALF-YEAR REPORT PSr 2007 Year

BGŻ Group. Presentation of Q1-Q results. Warsaw, 13 November 2013

WSE in H Investor Presentation. 30 August 2011

Call for proposals. for civil society capacity building and monitoring of the implementation of national Roma integration strategies

PRIVACY NOTICE. I. Indication of the data controller

European Federation of Pharmaceutical Industries and Associations (EFPIA) HCP/HCO Disclosure Transparency Requirements Methodology Note for Shire

COMPANY NEWS EDITION 8 November 2017 A WORD FROM OUR CEO

16 th edition of this popular report

Women s Health. Obstacles & Opportunities

PODRAVKA GROUP BUSINESS RESULTS FOR THE PERIOD JANUARY SEPTEMBER 2009

Independent Registered Auditor s Report

Eurostat publications cover nine themes:

RENEWABLE ENERGY AUCTIONS IN POLAND

Spis treści 1. PROFILE OF THE PARENT COMPANY General Information Toya S.A... 3

CCC S.A. CAPITAL GROUP CONSOLIDATED INTERIM REPORT FOR Q1 2014

INVITATION TO SUBMIT OFFERS TO SELL THE SHARES. of CPD S.A.

INSURANCE MARKET IN POLAND, CEE INSURANCE SERIES

RESEARCH TRAINING NETWORKS

Re.: Modifications in KDPW and KDPW_CCP IT systems scheduled in 2017

OPINION OF THE INDEPENDENT AUDITOR

High-Technology Trade Indicators 2008

MORTGAGE LENDING IN POLAND,

Version September Creating smart SEPA Solutions. A convenient and secure way to make payments. SEPA Direct Debit for Consumers

Cyfrowy Polsat IR Newsletter. 2 8 June 2014

Assessing financial inclusion in Portugal from the central bank s perspective

BANKING MARKET IN ROMANIA

Investment banking. Comprehensive solutions for businesses. Proven products for investors. Warsaw 2018

Medicines for Europe (MFE) HCP/HCO/PO Disclosure Transparency Requirements. Samsung Bioepis Methodology Note

FDI in Central, East and Southeast Europe: Recovery amid Stabilising Economic Growth

Giełda Papierów Wartościowych w Warszawie S.A. Group. Quarterly Report for Q3 2015

BANKING IN CEE: adequate risk appetite crucial to win the upside

IAB Europe AdEx Benchmark 2014

ecommerce in Romania Main Legal and Tax Aspects

Monetary and exchange rate policies in the Central and Eastern Europe: lessons and challenges. Jakub Borowski

MANAGEMENT BOARD OF ING BANK ŚLĄSKI SPÓŁKA AKCYJNA. hereby give notice of the

European Federation of Pharmaceutical Industries and Associations (EFPIA) HCP/HCO Disclosure Transparency Requirements. Biogen Methodology Note

Business Centre Club

DEMERGER PLAN RAIFFEISEN BANK POLSKA SPÓŁKA AKCYJNA. 28 April 2018

MCI Management SA publishes results for the year 2010

Retail Banking - Building a Growth Machine. By Aris Bogdaneris Board Member RI Group. The Current Environment. Slide 1. Slide 2

Cross-border VAT refunds for EU businesses

The Alior Bank S.A. Group. Report on the consolidated financial statements for the financial year ended 31 December 2015

The contents of this document must be taken into account by all individuals or entities that may have to make decisions or draw up or

Chapter II. Section 1. The following text is added at the beginning:

Funds and companies MCI Capital TFI

DOCUMENT HISTORY. Supersedes / Replaces. Version Effective Date Summary of Changes 01 30JUN2017 New Methodological Note

2018 TAX GUIDELINE. Poland.

Objectives and Investment Policy. Risk and Reward Profile

MERGER PLAN. involving CD PROJEKT S.A. and. Brand Projekt sp. z o.o.

INFORMATION ON THE PROCESSING OF PERSONAL DATA

CitiService News February 1, 2018 Edition No. 2

EFPIA Disclosure Code 2016 Disclosures Shire Pharmaceuticals (including Baxalta US Inc.)

1 General information

How to complete a payment application form (NI)

EBRD Communications Sector Assessment Conference. Activities of the TMT Team. 29 May 2009 Tbilisi

Banking Market Overview

PROPOSITION FOR SME COMPANIES

CIT rate development in CEE

Analytical annex to Recommendation to mitigate interest rate and interest rate-induced credit risk in long-term consumer loans

INDEPENDENT STATUTORY AUDITOR S OPINION AND REPORT. concerning a financial statement. of POLNA Spółka Akcyjna in Przemyśl

Purpose Explanation Legal basis Data processing duration

Claims Management Claim Form. When you have filled in the form, please send it to us at:

Transcription:

OTC market in Central and Eastern Europe 2008 Comparative analysis and development forecasts for 2008-2010 Publication date: September 2008 Language: English

A word from the authors At present, the OTC market in the CEE region is the main growth driver for the whole pharmaceutical segment in almost every country in the region. This is connected with intensive economic growth, unparalleled to satiated economies of Western Europe, and the change in consumer habits in the analysed region. The CEE region is currently a very attractive place to launch sales of OTC products for companies already present on the market, as well as for those who want to set up such an activity. Our aim was to compare eight most important CEE countries showing the most crucial characteristics of the region and particular markets. The OTC drug segment is extremely complicated mainly because of its close relationship with e.g. the food sector. Taking into account the increasing importance of the correlated segments of OTC products (the so called non-drug OTC products), we have attempted to classify these products and their values, in order to create a comprehensive picture of the self-medication market. Monika Stefanczyk, Head Pharmaceutical Analyst Agnieszka Stawarska, Pharmaceutical Analyst 2

PMR Marketinsight Methodology This report was prepared using PMR's MarketInsight Methodology. PMR MarketInsight is a methodology developed by PMR which assists in the complex preparation of industry reports. It defines the ways in which data should be collected for such reports and outlines the methods to be used in analysing the information collected in order to obtain a true picture of the market in question. It also contains special procedures to follow in the case of incomplete market PMR MarketInsight precisely defines report content and structure. Industry reports prepared using PMR MarketInsight are based on information from a variety of available statistical, industry (specialist press, the internet), general and official sources as well as information from PMR's own database and primary research independently carried out by PMR. The sources we use are individually tailored to each project. PMR MarketInsight is the result of over 10 years of experience in conducting industry analysis on Central and Eastern European markets. PMR MarketInsight M e t h o d o l o g y 3

In Russia, the nonpharmacy segment is dominated by dietary supplements. Report description OTC market in Central and Eastern Europe 2008 offers a detailed discussion of the OTC sector, with special attention given to its most important markets: Russia, Poland, Romania, Hungary, Ukraine, the Czech Republic, Bulgaria and Slovakia. The report is an indispensable guide for those considering entering or already active on the OTC market. It analyses the conditions governing business management and provides crucial information regarding the OTC market's present condition, as well as opportunities and obstacles for its future development. Useful data regarding distribution channels and profiles of the market's most important actors also constitute an important part of the publication. The report features a comparative analysis of eight Central and Eastern European countries with respect to the most important elements of the sector, which completes this exhaustive overview of the OTC market in Central and Eastern Europe. see how to order 4

Key sections Section one presents the most important characteristics of the OTC markets in Central and Eastern European countries. It provides data on its market value in a number of categories, main market trends and events in 2007 and 2008, OTC product prices and sales statistics, and a comprehensive comparison of OTC markets in CEE countries. In 2007, the OTC products market in the CEE region was worth some 7.4bn. This section also includes OTC market value forecasts for 2008-2010, prepared by PMR pharmaceutical and economy experts, and analyses the potential growth of the main OTC categories in particular countries in 2008-2010. Section two discusses the legal framework for advertising in each country, as well as OTC advertising spending, including a presentation of the larges advertisers and products that are most often advertised. This is followed by a comparative analysis of advertising markets in the discussed countries. Section three analyses market strategies and sales of major OTC manufacturers of local origin in the CEE region, and presents the main OTC producers in each of the discussed countries. It also features detailed profiles of the most important players of local origin in Central and Eastern Europe. Section four examines distribution channels on the OTC market, presenting segment profiles and major players in pharmaceutical wholesale and retail distribution. This is followed by a discussion of nonpharmacy and on-line sales conditions, as well as a comparison of OTC distribution across the CEE region. Section five delineates the most important factors influencing the OTC market in Central and Eastern Europe, including macroeconomic and demographic indicators, consumer behaviour regarding OTC intake, and epidemiological trends. CEE trends have been compared to those in Western European. see how to order 5

In 2007, in Poland, only 20% of pharmacy sales of medicines was generated by OTC drugs. Report overview The report opens with a presentation of the main characteristics of the OTC market in each of the analysed countries. It provides market data according to the following categories: notc market value by distribution channels notc market value by product category notc market value in 2005-2010 and OTC share on the pharmaceutical market notc drugs market by therapeutic categories ndietary supplements market value. Additionally the following market characteristics are discussed: nmain trends and events on the OTC market in 2007-2008 nprices of OTC products nrx to OTC switch nbest-selling OTC products ncomparative analysis of OTC markets in CEE: lotc share in the pharma market as a whole ldietary supplements' share in the OTC market ldevelopment of the largest OTC categories in years 2008-2010. see how to order 6

We then focus on OTC advertising, and particularly on its following aspects: nlegal framework nspending ncomparative analysis of drug advertising markets in CEE. Slovakia s economy is the most rapidly growing in CEE. The report then investigates the following OTC distribution channels in each of the discussed countries: npharmaceutical wholesalers lsegment profile lmajor players npharmacy distribution lsegment profile lmajor players non-pharmacy sales non-line sales ncomparative analysis of OTC distribution in CEE. This is followed by a presentation of key players of local origin operating on the OTC market in Central and Eastern Europe, with special focus on the following data: nmarket strategy per manufacturer notc sales per manufacturer ntop OTC producers per country. see how to order 7

Life expectancy at birth in the Czech Republic is the longest in the CEE region. Crucial information concerning factors most strongly influencing the market completes the report, with attention given to the following elements: nkey macroeconomic and demographic indicators in CEE countries lmacroeconomic overview ldemographics ldrug expenditures nconsumer behaviour regarding OTC intake in CEE lotc intake lpopularity of self-treatment lthe pharmacist as a source of information lphysical activity lchanges in eating habits lincidence of smoking lalcohol use luse of anti-depressants nepidemiological trends lsubjective assessment of individual health llife expectancy at birth loverweight and obesity lallergies lheadaches and other kinds of pain lpsychological problems ldiabetes lsight problems lstress lcomparison of CEE and Western Europe. see how to order 8

The report is a must-read for anyone looking for top quality business intelligence on the OTC market in Central and Eastern Europe, and particularly to: nthe senior management of companies active in the region ndecision makers of companies considering entering the market notc manufacturers and producers npharmaceutical wholesalers and distributors nnon-pharmacy and on-line drug distributors npharmacy managers nadvertising agencies nresearch and analytical institutions nembassies and other government institutions. CEE citizens are more likely to take drugs in case of ailments than Western European citizens. see how to order 9

Selected PMR clients: ratiopharm 10

080307 About PMR Ltd. Sp. z o.o. PMR Publications provides reliable market intelligence for business professionals interested in Central and Eastern European countries. Publications by PMR analyse the business climate in the region, in particular in the construction, retail, IT, telecommunications and pharmaceutical sectors. PMR Publications offers both free and paid subscription newsletters, internet news portals and indepth reports. To find out more about Poland and Central Eastern European countries please visit www.polishmarket.com and www.ceemarket.com as well as the regional and national sector portals dedicated to construction (www.constructionpoland.com, www.constructionrussia.com), IT and telecom (www.itandtelecompoland.com, www.ictrussia.com), retail (www.retailpoland.com, www.ceeretail.com, www.russiaretail.com) and pharma (www.pharmapoland.com). PMR Publications is a division of PMR Ltd. (www.pmrcorporate.com), a publishing, consulting and market research company providing information, advice and services to international businesses interested in Central and Eastern Europe. With highly skilled staff, top ranked web sites and over ten years of experience, PMR is one of the largest companies of its type in the region. PMR Ltd. Sp. z o.o., ul. Supniewskiego 9, 31-527 Krakow, Poland Questions about ordering? Contact our sales department: tel. /48/ 12 618 90 30 fax /48/ 12 618 90 08 e-mail: sales@pmrcorporate.com www.pmrpublications.com

SUBSCRIPTION CARD TO ORDER RETURN THE FORM TO US VIA FAX ON: /48/ 12 618 90 08 Please send me 1 2 Last YOUR LICENCE INVOICING DETAILS OTC market in Central and Eastern Europe 2008 Publication date: September 2008 Language: English Single user licence* 5-user licence** Corporate licence*** If your contact details are different to the invoicing details, please fax them to us together with the completed order form. Mr Mrs Ms Name Job title Country E-mail Tel./Fax Comparative analysis and development forecasts for 2008-2010 Core business First Name Company Invoicing address EU VAT Number Global licence**** English 2000 3000 4000 5000 * By ordering a single user licence the client is purchasing the right to use the publication on one computer workstation only. Any copying, distribution or dissemination of the electronic publication via a computer network (in part or in whole) is strictly prohibited. Delivered by e-mail in PDF format. ** By ordering a 5-user licence the client is purchasing a licence authorising the copying, distribution and dissemination of the electronic publication via a computer network (in part or in whole) among a maximum of 5 people within the company indicated on the order form (including all company subsidiaries in a single country location). Delivered by e-mail in PDF format. *** By ordering a company licence the client is purchasing a licence authorising the unrestricted copying, distribution and dissemination of the electronic publication (in part or in whole) via a computer network solely within the company indicated on the order form (including all company subsidiaries in a single country location). CD delivered by courier. CD version contains PDF version of the report plus an extra file with all the graphs and tables in a copiable format easy to use in your own analyses, presentations, etc. **** By ordering a global licence the client is purchasing a licence authorising the unrestricted copying, distribution and dissemination of the electronic publication (in part or in whole) via a computer network solely within the organisation indicated on the order form, regardless of country location. CD delivered by courier. CD version contains PDF version of the report plus an extra file with all the graphs and tables in a copiable format easy to use in your own analyses, presentations, etc. 3 4 PAYMENT FORM Subscription will be invoiced in PLN at current exchange rates. Polish clients need to add 22% VAT. Foreign clients will be invoiced in EURO. MONEY TRANSFER TO: PMR Ltd. Sp. z o.o. For Polish clients: Raiffeisen Bank Polska S.A. ul. Armii Krajowej 18, 30-150 Krakow Account number: 36 1750 1048 0000 0000 0758 5225 For foreign clients: Raiffeisen Bank S.A., ul. Armii Krajowej 18, 30-150 Krakow Account number: PL 92 1750 1048 0000 0000 0758 5284 SWIFT CODE: RCBWPLPW Correspondence address E-mail / Tel. to accounting CREDIT CARD: Diners Club Visa Eurocard / Mastercard American Express Account to be charged and currency (Credit card charges will be made in PLN at current exchange rates) Name of card owner Credit Card No Valid until Billing address of card I undertake to contact PMR Ltd. within seven days should I not receive any of the copies. In sending this form I authorise PMR Ltd. Sp. z o.o. to invoice me without my signature and to use the company details on the form for processing my subscription (Ustawa o ochronie danych osobowych Dz. U. nr 133/97, poz. 883) Signature: only signed forms can be processed Thank you! We will contact you soon to confirm your order. PMR Ltd. Sp. z o. o., tel. /48/ 12 618 90 00, fax /48/ 12 618 90 08, e-mail: sales@pmrcorporate.com, ul. Supniewskiego 9, 31-527 Kraków, Polska NIP number: 676-20-95-189, destination of region court: Sąd Rejonowy dla Krakowa-Śródmieścia w Krakowie XI Wydział Gospodarczy Krajowego Rejestru Sądowego, KRS number: 0000057694, the amount of company s nominal capital: one hundred and thirty thousand 221007